G1 Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GTHX and other ETFs, options, and stocks.

About GTHX

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. 

CEO
Jack Bailey
CEOJack Bailey
Employees
100
Employees100
Headquarters
Research Triangle Park, North Carolina
HeadquartersResearch Triangle Park, North Carolina
Founded
2008
Founded2008
Employees
100
Employees100

GTHX Key Statistics

Market cap
217.15M
Market cap217.15M
Price-Earnings ratio
-4.38
Price-Earnings ratio-4.38
Dividend yield
—
Dividend yield—
Average volume
744.73K
Average volume744.73K
High today
$4.31
High today$4.31
Low today
$4.04
Low today$4.04
Open price
$4.31
Open price$4.31
Volume
692.55K
Volume692.55K
52 Week high
$5.00
52 Week high$5.00
52 Week low
$1.08
52 Week low$1.08

GTHX News

Benzinga 7d
Breaking Down G1 Therapeutics: 5 Analysts Share Their Views - G1 Therapeutics - Benzinga

Loading... Loading... In the preceding three months, 5 analysts have released ratings for G1 Therapeutics GTHX, presenting a wide array of perspectives from bu...

Breaking Down G1 Therapeutics: 5 Analysts Share Their Views - G1 Therapeutics - Benzinga

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
0%
Sell
16.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.